Dual 68-Gallium/FDG PET imaging in neuroendocrine tumours

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Neuroendocrine tumours (NETs) are uncommon cancers. Low-grade tumours may grow very slowly and not require treatment, but high-grade tumours can grow over weeks and have a poor prognosis. Grade is determined by looking at tissue, but this may vary considerably even in different disease sites in the same patient. Two PET scans (FDG PET and 68Gallium PET) can show high grade and low grade disease respectively, and we plan to investigate their combination in imaging advanced neuroendocrine tumours.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2019

Funding Scheme: Postgraduate Scholarships

Funding Amount: $75,006.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Diagnosis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | cancer biology | diagnosis | nuclear medicine | prognosis